TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis.
Jung K, Choi JS, Koo BM, Kim YJ, Song JY, Sung M, Chang ES, Noh KW, An S, Lee MS, Song K, Lee H, Kim RN, Shin YK, Oh DY, Choi YL.
Jung K, et al. Among authors: kim yj, kim rn.
Cancer Res Treat. 2021 Jan;53(1):9-24. doi: 10.4143/crt.2020.434. Epub 2020 Sep 16.
Cancer Res Treat. 2021.
PMID: 32972043
Free PMC article.